HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads

PURPOSE: Monitoring HIV-1 drug resistance mutations (DRM) in treated patients on combination antiretroviral therapy (cART) with a detectable HIV-1 viral load (VL) is important for the selection of appropriate cART. Currently, there is limited data on HIV DRM at low-level viremia (LLV) (VL 401–999 co...

Descripción completa

Detalles Bibliográficos
Autores principales: Bareng, Ontlametse T, Choga, Wonderful T, Maphorisa, Segomotso T, Seselamarumo, Sekgabo, Seatla, Kaelo K, Mokgethi, Patrick T, Maruapula, Dorcas, Mogwele, Mompati L, Ditshwanelo, Doreen, Moraka, Natasha O, Gobe, Irene, Motswaledi, Modisa S, Makhema, Joseph M, Musonda, Rosemary, Shapiro, Roger, Essex, Max, Novitsky, Vlad, Moyo, Sikhulile, Gaseitsiwe, Simani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792565/
https://www.ncbi.nlm.nih.gov/pubmed/36582452
http://dx.doi.org/10.2147/IDR.S388816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792565/
https://www.ncbi.nlm.nih.gov/pubmed/36582452
http://dx.doi.org/10.2147/IDR.S388816

Ejemplares similares